HomeGRCE • NASDAQ
add
Grace Therapeutics, Inc
Previous close
$3.35
Day range
$3.33 - $3.44
Year range
$1.75 - $4.68
Market cap
51.84M USD
Avg Volume
60.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.53M | -47.65% |
Net income | -938.00K | 72.67% |
Net profit margin | — | — |
Earnings per share | -0.08 | 79.90% |
EBITDA | -2.53M | 47.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.86M | 11.15% |
Total assets | 66.58M | 1.88% |
Total liabilities | 3.76M | -59.22% |
Total equity | 62.82M | — |
Shares outstanding | 14.13M | — |
Price to book | 0.75 | — |
Return on assets | -9.27% | — |
Return on capital | -10.01% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -938.00K | 72.67% |
Cash from operations | -3.14M | 25.86% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -3.14M | 25.86% |
Free cash flow | -2.36M | 9.67% |
About
Founded
2002
Website
Employees
6
